Israel Englander Magenta Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.36 - $1.59 $78,555 - $346,953	218,210 Added 10.41%	2,313,552 $914,000
Q3 2022 Nov 14, 2022	BUY	$1.26 - $2.09 $277,133 - $459,689	219,947 Added 11.73%	2,095,342 $2.95 Million
Q2 2022 Aug 15, 2022	BUY	$0.97 - $3.08 $457,446 - $1.45 Million	471,594 Added 33.59%	1,875,395 $2.25 Million
Q1 2022 May 16, 2022	BUY	$2.55 - $5.23 $1.84 Million - $3.77 Million	720,201 Added 105.35%	1,403,801 $4.07 Million
Q4 2021 Feb 14, 2022	BUY	$4.43 - $8.33 $3.03 Million - $5.69 Million	683,600 New	683,600 $3.03 Million
Q3 2021 Nov 15, 2021	SELL	$6.07 - $9.89 $389,178 - $634,097	-64,115 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.76 - $14.15 $202,666 - $293,824	20,765 Added 47.9%	64,115 $627,000
Q1 2021 May 17, 2021	SELL	$7.66 - $13.38 $166,988 - $291,684	-21,800 Reduced 33.46%	43,350 $513,000
Q4 2020 Feb 16, 2021	BUY	$6.1 - $7.94 $169,695 - $220,882	27,819 Added 74.52%	65,150 $511,000
Q3 2020 Nov 16, 2020	SELL	$6.52 - $8.94 $1.58 Million - $2.17 Million	-242,884 Reduced 86.68%	37,331 $254,000
Q2 2020 Aug 14, 2020	BUY	$6.18 - $10.76 $277,889 - $483,834	44,966 Added 19.11%	280,215 $2.1 Million
Q1 2020 May 14, 2020	BUY	$6.03 - $15.24 $665,036 - $1.68 Million	110,288 Added 88.26%	235,249 $1.48 Million
Q4 2019 Feb 14, 2020	BUY	$9.07 - $15.84 $1.13 Million - $1.98 Million	124,961 New	124,961 $1.89 Million
Q3 2018 Nov 14, 2018	SELL	$11.32 - $15.7 $1.26 Million - $1.75 Million	-111,736 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.5 - $14.52 $1.51 Million - $1.62 Million	111,736 New	111,736 $1.51 Million

Others Institutions Holding MGTA

# of Institutions

Shares Held

442K

Call Options Held

Put Options Held

Hellman Jordan Management CO Inc Quincy, MA

441K
Shares

$0
0.3% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.3K
Shares

$0
0.0% of portfolio

View Full List

About Magenta Therapeutics, Inc.

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

More about MGTA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account